We also found that HFpEF patients with insulin‐treated diabetes had worse health‐related quality of life and were twice as likely to experience CV death or HF hospitalization, even after extensive adjustment for other prognostic variables including NT‐proBNP and eGFR. This evidence concerns the gene INS and hydrops fetalis.